Kirsten Flowers - Net Worth and Insider Trading
Kirsten Flowers Net Worth
The estimated net worth of Kirsten Flowers is at least $436,857 dollars as of 2024-05-27. Kirsten Flowers is the CCO & Chief Strategy Officer of Kura Oncology Inc and owns about 20,605 shares of Kura Oncology Inc (KURA) stock worth over $436,208. Kirsten Flowers is also the Director of Comera Life Sciences Holdings Inc and owns about 22,199 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $649. Details can be seen in Kirsten Flowers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kirsten Flowers has not made any transactions after 2023-01-27 and currently still holds the listed stock(s).
Transaction Summary of Kirsten Flowers
Kirsten Flowers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kirsten Flowers owns 3 companies in total, including Kura Oncology Inc (KURA) , PMV Pharmaceuticals Inc (PMVP) , and Comera Life Sciences Holdings Inc (CMRA) .
Click here to see the complete history of Kirsten Flowers’s form 4 insider trades.
Insider Ownership Summary of Kirsten Flowers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KURA | Kura Oncology Inc | 2023-01-27 | Chief Commercial Officer |
| PMVP | PMV Pharmaceuticals Inc | 2022-01-05 | director |
| CMRA | Comera Life Sciences Holdings Inc | 2023-01-04 | director |
Kirsten Flowers Latest Holdings Summary
Kirsten Flowers currently owns a total of 2 stocks. Among these stocks, Kirsten Flowers owns 20,605 shares of Kura Oncology Inc (KURA) as of January 27, 2023, with a value of $436,208 and a weighting of 99.85%. Kirsten Flowers also owns 22,199 shares of Comera Life Sciences Holdings Inc (CMRA) as of January 4, 2023, with a value of $649 and a weighting of 0.15%.
Latest Holdings of Kirsten Flowers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KURA | Kura Oncology Inc | 2023-01-27 | 20,605 | 21.17 | 436,208 |
| CMRA | Comera Life Sciences Holdings Inc | 2023-01-04 | 22,199 | 0.03 | 649 |
Holding Weightings of Kirsten Flowers
Kirsten Flowers Form 4 Trading Tracker
According to the SEC Form 4 filings, Kirsten Flowers has made a total of 1 transactions in Kura Oncology Inc (KURA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kura Oncology Inc is the sale of 1,906 shares on January 27, 2023, which brought Kirsten Flowers around $26,474.
According to the SEC Form 4 filings, Kirsten Flowers has made a total of 1 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 13,513 shares on January 4, 2023, which cost Kirsten Flowers around $16,621.
Insider Trading History of Kirsten Flowers
- 1
Kirsten Flowers Trading Performance
GuruFocus tracks the stock performance after each of Kirsten Flowers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kirsten Flowers is -31.78%. GuruFocus also compares Kirsten Flowers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kirsten Flowers within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kirsten Flowers's insider trading performs compared to the benchmark.
Performance of Kirsten Flowers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.33 | | | | | |
| Relative Return to S&P 500(%) | -5.03 | | | | | |
Kirsten Flowers Ownership Network
Kirsten Flowers Owned Company Details
What does Kura Oncology Inc do?
Who are the key executives at Kura Oncology Inc?
Kirsten Flowers is the Chief Commercial Officer of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Legal Officer Teresa Brophy Bair , Chief Medical Officer Stephen Dale , and SVP & Finance & Accounting Thomas James Doyle .
Kura Oncology Inc (KURA) Insider Trades Summary
Over the past 18 months, Kirsten Flowers made 1 insider transaction in Kura Oncology Inc (KURA) with a net sale of 1,906. Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 21,208 shares made by Stephen Dale , a net sale of 4,668 shares made by Teresa Brophy Bair , and a net sale of 3,866 shares made by Thomas James Doyle .
In summary, during the past 3 months, insiders sold 2,615 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 2,615 shares. During the past 18 months, 126,017 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 76,017 shares.
Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kura Oncology Inc Insider Transactions
Kirsten Flowers Mailing Address
Above is the net worth, insider trading, and ownership report for Kirsten Flowers. You might contact Kirsten Flowers via mailing address: C/o Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
